Conviction
$ Value
$4.8M
Shares
300,000
Price
$16
Filed
Mar 2
▶ Why this score? (8/10)
- ✓ Open market buy (+3)
- ✓ Trade value >= $1.0M (+2)
- ✓ Director (+1)
- ✓ 10%+ owner (+1)
- ✓ Not a 10b5-1 plan (+1)
Insider
Name
RA CAPITAL MANAGEMENT, L.P.
Title
—
CIK
0001346824
Roles
Transaction Details
Transaction Date
2026-02-26
Code
P
Table
Non-Derivative
Ownership
Indirect
Equity Swap
No
Shares After
4,603,418
Footnotes
RA Capital Management, L.P. (the "Adviser") is the investment manager for RA Capital Healthcare Fund, L.P. (the "Fund") and RA Capital Nexus Fund III, L.P. (the "Nexus Fund III"). The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. Each of the Adviser, the Adviser GP, the Fund, the Nexus Fund III, Dr. Kolchinsky and Mr. Shah disclaims beneficial ownership of any of the reported securities, except to the extent of its or his respective pecuniary interest therein. | Held directly by the Fund. | Held directly by Nexus Fund III. | The Pre-Funded Warrants have no expiration date and are exercisable at any time after the date of issuance. A holder of Pre-Funded Warrants may not exercise the Pre-Funded Warrant if the holder, together with its affiliates, would beneficially own more than 9.99% of the number of shares of common stock outstanding immediately after giving effect to such exercise.
Filing Info
RA CAPITAL MANAGEMENT, L.P.'s History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-22 | ACRV | A | $7.0M |
| 2026-04-20 | VOR | ▼ | $2.7M |
| 2026-04-17 | VOR | ▼ | $7.5M |
| 2026-04-15 | VOR | ▼ | $859K |
| 2026-04-14 | VOR | ▼ | $2.5M |
| 2026-04-13 | VOR | ▼ | $8.6M |
| 2026-04-10 | VOR | ▼ | $13K |
| 2026-04-09 | VOR | ▼ | $2.2M |
| 2026-04-08 | VOR | ▼ | $5.8M |
| 2026-04-08 | VOR | ▼ | $2.2M |
Other Insiders at BCAX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | $35.2M | — | 2026-02-26 |
|
Meisner Lara
Chief Legal Officer
|
— | — | 2026-02-02 |
|
Cohlhepp Ryan
President and COO
|
— | $984K | 2026-04-15 |
|
Hyep Ivan
Chief Financial Officer
|
— | $717K | 2026-04-21 |
|
Mazumdar Claire
Chief Executive Officer
|
— | $1.5M | 2026-04-20 |
|
Raben David
Chief Medical Officer
|
— | $410K | 2026-03-25 |